• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PatientsLikeMe names Greg Ploussios SVP and General Counsel

PatientsLikeMe names Greg Ploussios SVP and General Counsel

August 3, 2017
CenterWatch Staff

PatientsLikeMe has named Greg Ploussios to the newly-created role of Senior Vice President and General Counsel. Prior to joining PatientsLikeMe, Ploussios served as the company’s outside counsel for over a decade, advising and negotiating PatientsLikeMe’s licensing, collaboration and commercial agreements and representing the company in equity financing, mergers and acquisitions, and other corporate matters, including its recent financing and partnership with iCarbonX.

As Senior Vice President and General Counsel, Ploussios will take a more active role in overseeing PatientsLikeMe’s legal needs, including licensing, collaboration and commercial agreements, equity financing, privacy, and regulatory compliance.

Before joining PatientsLikeMe, Ploussios was a partner at Foley Hoag in the business department, where he co-chaired the firm’s Licensing & Strategic Alliance Practice. Prior to that he was a partner at Edwards Angell Palmer & Dodge. Ploussios’s practice has focused on representing information technology, software, Internet, bioinformatics, and medical device clients with an emphasis on licensing and commercial transactions, as well as venture capital and private equity investments and general corporate representation. Ploussios has advised numerous technology startups as well as more mature companies, including PTC, Delphi Technology, Nlyte Software, Karen Clark & Company, and Houghton Mifflin Harcourt Publishing. Ploussios started his legal career in 1996 as a summer associate at Palmer & Dodge.

“What I love about Greg is he's a lawyer who codes for fun. His unique mix of technical knowledge and legal acumen has made him an invaluable advisor over the years," said Co-Founder and President Ben Heywood. “He’ll be an even greater asset as a partner in the business as we explore new frontiers where ethical, legal and regulatory questions converge.”

Ploussios holds a Juris Doctor from Boston University School of Law and a Bachelor of Arts degree from the University of Michigan, with a double major in English and Political Science. He resides in Newton, Massachusetts.

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing